208 related articles for article (PubMed ID: 15213595)
1. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data.
Gilks CB
Int J Gynecol Pathol; 2004 Jul; 23(3):200-5. PubMed ID: 15213595
[TBL] [Abstract][Full Text] [Related]
2. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
3. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
4. New insights into ovarian cancer pathology.
Prat J
Ann Oncol; 2012 Sep; 23 Suppl 10():x111-7. PubMed ID: 22987944
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of epithelial ovarian cancer.
Christie M; Oehler MK
J Br Menopause Soc; 2006 Jun; 12(2):57-63. PubMed ID: 16776856
[TBL] [Abstract][Full Text] [Related]
6. Pathology of borderline and invasive cancers.
Prat J
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():15-30. PubMed ID: 28277307
[TBL] [Abstract][Full Text] [Related]
7. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.
Lalwani N; Prasad SR; Vikram R; Shanbhogue AK; Huettner PC; Fasih N
Radiographics; 2011; 31(3):625-46. PubMed ID: 21571648
[TBL] [Abstract][Full Text] [Related]
8. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
Taylor J; McCluggage WG
Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
Kurman RJ; Shih IeM
Hum Pathol; 2011 Jul; 42(7):918-31. PubMed ID: 21683865
[TBL] [Abstract][Full Text] [Related]
10. Origins and molecular pathology of ovarian cancer.
Bell DA
Mod Pathol; 2005 Feb; 18 Suppl 2():S19-32. PubMed ID: 15761464
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
12. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
13. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
Dehari R; Kurman RJ; Logani S; Shih IeM
Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
[TBL] [Abstract][Full Text] [Related]
14. The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of "borderline" ovarian tumors.
Lawrence WD
Cancer; 1995 Nov; 76(10 Suppl):2138-42. PubMed ID: 8635013
[TBL] [Abstract][Full Text] [Related]
15. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
Giurgea LN; Ungureanu C; Mihailovici MS
Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
[TBL] [Abstract][Full Text] [Related]
16. Histologic subtypes of ovarian carcinoma: an overview.
Soslow RA
Int J Gynecol Pathol; 2008 Apr; 27(2):161-74. PubMed ID: 18317227
[TBL] [Abstract][Full Text] [Related]
17. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
18. Observer disagreement in histological classification of ovarian tumors in Japan.
Sakamoto A; Sasaki H; Furusato M; Suzuki M; Hirai Y; Tsugane S; Fukushima M; Terashima Y
Gynecol Oncol; 1994 Jul; 54(1):54-8. PubMed ID: 8020839
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
20. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
Shih IeM; Kurman RJ
Am J Pathol; 2004 May; 164(5):1511-8. PubMed ID: 15111296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]